MedTrace Logo

Response of Intracardiac Thrombus to Anticoagulants in Patients With Non-valvular Atrial Fibrillation (LYSIS)

NCT06141538 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-04-04

No results posted yet for this study

Summary

This study aims to analyze changes in the immune status, metabolic status, and host microbiome community structure in non-valvular atrial fibrillation patients with intracardiac thrombus. Additionally, the study aims to analyze factors that influence the responsiveness and occurrence of adverse events related to anticoagulant therapy.

Conditions

Interventions

OTHER

Observational; No Interventions were given.

Observational; No Interventions were given.

Sponsors & Collaborators

  • 521 Hospital of NORINCO Group

    collaborator OTHER

  • Shaanxi Provincial People's Hospital

    collaborator OTHER

  • Xiangyang Central Hospital

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Guoliang Li · First Affiliated Hospital Xi'an Jiaotong University

  • Chaofeng Sun · First Affiliated Hospital Xi'an Jiaotong University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2030-07-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06141538 on ClinicalTrials.gov